Tirzepatide in Metabolically Dysfunctional-Associated Steatohepatitis (MASH): A Bibliometric and Evidence-Based Review [0.03%]
替扎パタ肽在代谢性失调相关性肝炎（MASH）中的作用：基于文献计量学和证据的综述
Ileana Pantea,Angela Repanovici
Ileana Pantea
Purpose: Metabolically-dysfunction-associated steatohepatitis (MASH) is the progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD) and is strongly linked to obesity and type 2 diabetes mellit...
Effectiveness of Wearable Devices for Diabetes Management: An Overview of Systematic Reviews and Meta-Analyses [0.03%]
可穿戴设备辅助糖尿病管理的效果：系统评价和meta分析的概要
Muxiarepu Talaiti,Xiaoqin Liao,Nuerguli Abulimiti et al.
Muxiarepu Talaiti et al.
Objective: Wearable devices play an important role in managing diabetic patients, and patient demand for them is also on the rise. This overview systematically summarizes and appraises the current evidence on wearable dev...
Collaboration Around Technology Using Community Health Workers in Type 1 Diabetes (CATCH-T1D): Protocol and Preliminary Results for a Randomized Controlled Trial [0.03%]
基于社区的卫生工作者技术合作在1型糖尿病中的应用（CATCH-T1D）：协议及初步结果的随机对照试验
Shivani Agarwal,Molly Finnan,Kevin P Fiori et al.
Shivani Agarwal et al.
Background: Diabetes technology use in Type 1 diabetes (T1D) is the standard of care given broad biological and psychosocial benefits. Hispanic and Non-Hispanic Black young adults are the fastest-growing demographic with ...
Screening Autophagy-Related DKD Biomarkers Based on Bulk RNA and Single-Cell Analysis and Uncovering Their Regulatory Mechanisms in DKD Renal Fibrosis [0.03%]
基于批量RNA和单细胞分析筛查自噬相关DKD生物标志物及其在DKD肾纤维化中的调控机制研究
Qin Wang,Xiaoqi Li,Wen Ye et al.
Qin Wang et al.
Background: Diabetic kidney disease (DKD) is a common diabetes complication that increases global morbidity and mortality. To identify DKD biomarkers and explore autophagy-related mechanisms to find potential therapeutic ...
Machine Learning-Based Prediction Model Construction for Type 2 Diabetes Mellitus: A Comparison of Algorithms and Multilevel Risk Factor Analysis [0.03%]
基于机器学习的2型糖尿病预测模型构建及算法与多水平风险因素比较分析
Qian Xu,Ruicong Yu,Huixin Qiu et al.
Qian Xu et al.
Background: Against the backdrop of the global high incidence of Type 2 diabetes mellitus (T2DM), existing prediction models are largely confined to single-dimensional risk factors, suffering from a core limitation of lac...
Comparative Study
Journal of diabetes research. 2026;2026(1):e4525736. DOI:10.1155/jdr/4525736 2026
'If You Cut Me, I'd Probably Bleed Coca-Cola': A Qualitative Exploration of Barriers and Facilitators to Type 2 Diabetes Management Among Chinese Adults in the UK [0.03%]
“如果伤到我，我的鲜血会是可口可乐色的”——定性探究在英中国成年人中第2型糖尿病管理之障碍及促进因素
Tarnjit Sehmbi,Ran Cao,Raju Sapkota et al.
Tarnjit Sehmbi et al.
Objectives: Chinese populations are at an elevated risk of type 2 diabetes mellitus (T2DM) and related complications, yet limited research has explored diabetes self-management in the UK Chinese community. This study aime...
Confidence to Self-Manage in Diabetes: An All-Wales Cross-Sectional Population Study [0.03%]
全威尔士糖尿病自我管理的跨区域人口学研究
Jasmine Rollings,Nichola M Thuvesholmen,Katherine E Woolley et al.
Jasmine Rollings et al.
Introduction: Diabetes is a leading cause of morbidity and mortality in Wales, and concerningly, the prevalence of diabetes and the associated healthcare costs continue to rise. Effective self-management is essential in d...
Comparative Efficacy, Safety, and Cost-Utility of DPP-4 Inhibitors and Metformin Combination Therapy in Type 2 Diabetes: A Systematic Review of Real-World Clinical and Economic Outcomes [0.03%]
二甲双胍与DPP-4抑制剂联合治疗2型糖尿病的疗效、安全性及成本效益：真实世界临床和经济学效果系统评价
Abdulgafar Olayiwola Jimoh,Shuaibu Abdullahi Hudu,Anas Ahmad Sabir et al.
Abdulgafar Olayiwola Jimoh et al.
Introduction: The management of type 2 diabetes with metformin as the first-line therapy has long been established. However, combination therapy of metformin and other oral antidiabetics became necessary to achieve optima...
Gut Microbiota and Dyslipidemia in Type 2 Diabetes: A Pilot Study of 16S rRNA Profiles and Predicted Functional Shifts [0.03%]
2型糖尿病患者肠道菌群与血脂异常的相关性：一项基于16SrRNA测序的前瞻性队列研究
Godfred Antony Menezes,Priyadharshini Sekar,Areebah Akhter et al.
Godfred Antony Menezes et al.
Hyperlipidemia is a major, modifiable driver of global cardiovascular risk. The intestinal microbiota, comprising bacteria, archaea, fungi, and viruses, modulates lipid metabolism through bile acid transformation, energy harvest, and inflam...
Network Pharmacology Combined With Gut Microbiome and Serum Metabolomics Reveals the Therapeutic Mechanisms of Hydroxysafflor Yellow A in Diabetic Kidney Disease [0.03%]
网络药理学结合肠道菌群和血清代谢组学揭示了羟基红花黄色素A治疗糖尿病肾病的机制
Pingping Wang,Xinyu Liu,Wen Sun et al.
Pingping Wang et al.
Diabetic kidney disease (DKD) is a severe complication of diabetes, primarily driven by chronic inflammation, oxidative stress, and gut microbiota dysbiosis. Hydroxysafflor yellow A (HSY), a bioactive compound derived from Carthamus tinctor...